Rajeev SP, Roberts CA, Brown E, Sprung VS, et al. No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE). Diabetes Obes Metab 2023 Sep 5. doi: 10.1111/dom.15257.
PMID: 37667658